PATIENTENDREHVORRICHTUNG

European patent · EP3700486 · In force

Register entry

Publication number
EP3700486
Application number
EP18797076
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 29, 2018
Published
Sep 2, 2020
Granted
Sep 27, 2023
Protection ends at the latest
Oct 28, 2038
Next annual fee due
Oct 31, 2027
IPC classes
A61G 7/00 (2006.01)
A61G 7/057 (2006.01)
Priority
GB 201717674 27.10.2017
PCT application
PCT/GB2018/053126 29.10.2018
PCT publication
WO2019/081954 02.05.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.10.2026 → 31.10.2027

    Published in Swissreg on 01.11.2026

  2. Nov 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.10.2025 → 31.10.2026

    Published in Swissreg on 01.11.2025

  3. Nov 1, 2024

    Next annual fee due on

    Next annual fee due on
    31.10.2024 → 31.10.2025

    Published in Swissreg on 01.11.2024

  4. Aug 8, 2024

    Change

    Published in Swissreg on 08.08.2024

  5. Dec 27, 2023

    Change

    Published in Swissreg on 27.12.2023

  6. Dec 22, 2023

    Agent entered

    Representative
    GERMAIN ET MAUREAU, Rue du Commerce 4, 1204 Genève

    Published in Swissreg on 22.12.2023

  7. Sep 27, 2023

    Granted

    Published in Swissreg on 27.09.2023

Parties

Holder

Frontier Therapeutics Limited

Newbridge Road Industrial Estate, Blackwood, Gwent NP12 2YN, GB

Agent

GERMAIN ET MAUREAU

1204 Genève

Inventor

WEBBER, Lewys

Blackwood Gwent NP12 2YN, GB

BOSLEY, Simon

Blackwood Gwent NP12 2YN, GB

MORSE, Jonathan

Blackwood Gwent NP12 2YN, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.